Global Computational Biology Market Expected to Achieve 23.5% CAGR by 2029: Growth Forecast Insights

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Computational Biology Market Size By 2025?
In the past few years, the computational biology market has seen a meteoric rise. The size of this market is projected to increase from $8.09 billion in 2024 to $9.47 billion in 2025, with a compound annual growth rate (CAGR) of 17.0%. Factors such as the integration of multi-omics, the advent of precision healthcare and personalized medicine, the genomic sequencing boom, and the management of voluminous biological data have fueled this growth during the historical period.

How Big Is the Computational Biology Market Size Expected to Grow by 2029?
Expectations are high for the computational biology market. It's predicted that the sector would experience major growth in the coming years, reaching a value of $22.04 billion in 2029, with a compound annual growth rate (CAGR) of 23.5%. The driving force behind this projected growth includes the integration of cloud and high-performance computing (HPC), the adoption of quantitative and predictive biology, interdisciplinary collaborative research, and progress in bioinformatics and computation tools. Along the forecast period, the market growth will be further complemented by evolutions in data science and bioinformatics, advancements in genomic sequencing technologies, the implementation of machine learning and AI in bioinformatics, advancements in drug discovery and development, as well as the rise of personalized medicine and precision healthcare.

View the full report here:
https://www.thebusinessresearchcompany.com/report/computational-biology-global-market-report

Which Key Market Drivers Powering Computational Biology Market Expansion and Growth?
The primary propellant for progress in the computational biology market has been government funding. Infrastructure and academic programs intended to enhance the proficiency of computational biologics across different sectors, such as R&D and educational institutions, are being supported globally by governmental bodies. Augmented government investments are anticipated to escalate the need for computational biology solutions, owing to their extensive applications in R&D, clinical research, and various developmental pursuits. For example, the National Cancer Institute (NCI), a governmental agency based in the United States, had an overall budget of $6.4 billion in April 2023. This included a $195 million contribution from the CURES Act, illustrating a 1.6 percent growth or an extra $99.3 million in comparison to the previous fiscal year. Thus, the progression of the computational biology market is profoundly influenced by government funding.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7131&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Computational Biology Market?
The computational biology market sees significant innovation as top companies devise new solutions to benefit proteomics research and solidify their market standing. Proteomics research constitutes an area of scientific exploration that concentrates on a detailed analysis of proteins within a biological system. For example, in May 2023, a biotechnology firm based in Switzerland, Biognosys AG, introduced Spectronaut 18, bringing forth important scientific and technological advancements tailored to its specialized proteomics research software and services. Spectronaut 18 guarantees high productivity and efficacy in data-independent acquisition (DIA) proteomics evaluation. The company's proprietary platform, TrueDiscovery, hastens biomarker identification in domains such as oncology and neuroscience by offering unmatched depth and sensitivity in proteomics. TrueTarget facilitates precise drug target identification and deconvolution, while the Biognosys' iRT Kit, suggested for real-time system suitability monitoring, is now compatible with Bruker ProteoScape software.

What Are the Emerging Segments in the Computational Biology Market?
The computational biologymarket covered in this report is segmented -

1) By Services: In-house, Contract
2) By Tools: Databases, Infrastructure (Hardware), Analysis Software and Services
3) By Application: Cellular and Biological Simulation, Drug Discovery and Disease Modelling, Clinical Trials
4) By End Users: Research, Pharmaceutical Industry, Commercial Applications

Subsegments:
1) By In-house: Data Analysis, Software Development, Research And Development
2) By Contract: Outsourced Bioinformatics, Collaborative Research, Data Management Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7131&type=smp

Who Are the Global Leaders in the Computational Biology Market?
Major companies operating in the computational biology market include Certara L. P, Chemical Computing Group Inc., Compugen Ltd., Genedata AG, Insilico Biotechnology AG, Dassault Systèmes SE, Instem PLC, Rosa & Co. LLC, Simulation Plus Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Leadscope Inc., DNAnexus, Altaris Capital Partner, Genialis Inc., Inari Agriculture Inc., BC Platforms, Ventus Therapeutics, Monte Rosa Therapeutics, Schrodinger Inc., Strand Life Sciences, Entos Pharmaceuticals, Numerate Inc., Insitro, Recursion Pharmaceuticals, Atomwise, Relay Therapeutics, Exscientia

Which are the Top Profitable Regional Markets for the Computational Biology Industry?
North America was the largest region in the computational biology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the computational biology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7131

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.